Related references
Note: Only part of the references are listed.Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy
Benjamin L. Wright et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
Julia Schanin et al.
MUCOSAL IMMUNOLOGY (2021)
Orally desensitized mast cells form a regulatory network with Treg cells for the control of food allergy
Yoshihiro Takasato et al.
MUCOSAL IMMUNOLOGY (2021)
Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions
Luke F. Pennington et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Intranasal nanoemulsion vaccine confers long-lasting immunomodulation and sustained unresponsiveness in a murine model of milk allergy
Jessica J. O'Konek et al.
ALLERGY (2020)
Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity
Angelika Tscheppe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis A Phase 3 Randomized Clinical Trial
Eric L. Simpson et al.
JAMA DERMATOLOGY (2020)
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
Audrey Le Floc'h et al.
ALLERGY (2020)
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial
Amy S. Paller et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2020)
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens
Federico Storni et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Disruptive anti-IgE inhibitors prevent mast cell-dependent early airway response in viable atopic lung tissue
Sharon Jimenez Delgado et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Rapid desensitization of humanized mice with anti-human Fc epsilon RI alpha monoclonal antibodies
Marat V. Khodoun et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Allergic inflammation is initiated by IL-33-dependent crosstalk between mast cells and basophils
Chia-Lin Hsu et al.
PLOS ONE (2020)
The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
Pascal Gasser et al.
NATURE COMMUNICATIONS (2020)
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis A Randomized Clinical Trial
Margitta Worm et al.
JAMA DERMATOLOGY (2020)
Sialylation of immunoglobulin E is a determinant of allergic pathogenicity
Kai-Ting C. Shade et al.
NATURE (2020)
Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy
Alexandra Langlois et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2020)
An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells
Sheena C. Kerr et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma
Gail M. Gauvreau et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis
Melanie C. Dispenza et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
Jonathan O'BHourihane et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis
Evan S. Dellon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy
Cynthia Kanagaratham et al.
FRONTIERS IN IMMUNOLOGY (2020)
Targeting Glycosylation: A New Road for Cancer Drug Discovery
Ana Filipa Costa et al.
TRENDS IN CANCER (2020)
A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut Allergy
Federico Storni et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2020)
Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy
Tonje Reier-Nilsen et al.
ALLERGY (2019)
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy The PEPITES Randomized Clinical Trial
David M. Fleischer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen
Shiteng Duan et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The use of biologics for immune modulation in allergic disease
Willem van de Veen et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Mannosylated Nanoparticles for Oral Immunotherapy in a Murine Model of Peanut Allergy
Ana Brotons-Canto et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Impact of Omalizumab on Food Allergy in Patients Treated for Asthma: A Real-Life Study
Alessandro Fiocchi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma
Ioana Agache et al.
ALLERGY (2019)
Peanut-allergic patient experiences after epicutaneous immunotherapy: peanut consumption and impact on QoL
Megan O. Lewis et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Mechanical Skin Injury Promotes Food Anaphylaxis by Driving Intestinal Mast Cell Expansion
Juan-Manuel Leyva-Castillo et al.
IMMUNITY (2019)
Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019
Gilda Varricchi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety
Derek K. Chu et al.
LANCET (2019)
Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergen
Peter E. Deak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents
Josef Brandstrom et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2019)
Pathomechanism of dupilumab-associated inflammatory eye symptoms
J. Wohlrab et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Divergent Effects of Acute and Prolonged Interleukin 33 Exposure on Mast Cell IgE-Mediated Functions
Elin Ronnberg et al.
FRONTIERS IN IMMUNOLOGY (2019)
Epitope targeting with self-assembled peptide vaccines
David F. Zeigler et al.
NPJ VACCINES (2019)
Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergy
Benjamin C. Remington et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Long-term sublingual immunotherapy for peanut allergy in children: Clinical and immunologic evidence of desensitization
Edwin H. Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Claus Bachert et al.
LANCET (2019)
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study
R. Sharon Chinthrajah et al.
LANCET (2019)
Recent developments and highlights in food allergy
Thomas Eiwegger et al.
ALLERGY (2019)
Dupilumab for treatment of food allergy
Manuel Jorge Rial et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab
Christina S. K. Yee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Ligelizumab for Chronic Spontaneous Urticaria
Marcus Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy
Katharina Blumchen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
IL-4 receptor a blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma
D. Russkamp et al.
ALLERGY (2019)
Nasal peanut plus CpG immunotherapy enhances peanut-specific IFN-γ in Th2 cells and IL-10 in non-Th2 cells in mice
Brandi T. Johnson-Weaver et al.
ALLERGY (2019)
IL-33 mediated amplification of allergic response in human mast cells
Shahana Parveen et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2019)
Successful treatment of idiopathic mast cell activation syndrome with low-dose Omalizumab
Renee Berry et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice
Bradford A. Youngblood et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy
Sharon Chinthrajah et al.
JCI INSIGHT (2019)
The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease
Jessica C. Anania et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals
Sandra Andorf et al.
ECLINICALMEDICINE (2019)
Development of a tool predicting severity of allergic reaction during peanut challenge
R. Sharon Chinthrajah et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function
A. Abdel-Gadir et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2018)
Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
Mirela Curin et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2018)
Human eosinophils and mast cells: Birds of a feather flock together
Piper A. Y. Robida et al.
IMMUNOLOGICAL REVIEWS (2018)
Mast cells as sources of cytokines, chemokines, and growth factors
Kaori Mukai et al.
IMMUNOLOGICAL REVIEWS (2018)
An overview of mast cell pattern recognition receptors
Justyna Agier et al.
INFLAMMATION RESEARCH (2018)
Short-term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy
Melanie C. Dispenza et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance
Oliver T. Burton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector TH2 subsets
David Chiang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma
Steven F. Weinstein et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells
Jeremy A. O'Sullivan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence
Marcus Maurer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Mechanisms of food allergy
Hugh A. Sampson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Prevention of food allergy development and suppression of established food allergy by neutralization of thymic stromal lymphopoietin, IL-25, and IL-33
Marat V. Khodoun et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tissue-specific expression of the low-affinity IgG receptor, FcγRIIb, on human Mast cells
Oliver T. Burton et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tuning the Cytokine Responses: An Update on interleukin (IL)-4 and IL-13 Receptor Complexes
Ilkka S. Junttila
FRONTIERS IN IMMUNOLOGY (2018)
DNA and mRNA vaccination against allergies
Sandra Scheiblhofer et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2018)
The Epidemiology of Food Allergy in the Global Context
Wenyin Loh et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
Adjuvanted Immunotherapy Approaches for Peanut Allergy
Brandi T. Johnson-Weaver et al.
FRONTIERS IN IMMUNOLOGY (2018)
AR101 Oral Immunotherapy for Peanut Allergy
Brian P. Vickery et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
Joyce Lubbers et al.
FRONTIERS IN IMMUNOLOGY (2018)
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
G. J. Sturm et al.
ALLERGY (2018)
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
G. Roberts et al.
ALLERGY (2018)
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy
G. B. Pajno et al.
ALLERGY (2018)
Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial
Sandra Andorf et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Potential applications of Bruton's tyrosine kinase inhibitors for the prevention of allergic reactions
Melanie C. Dispenza et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
LONG-TERM MANAGEMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH DUPILUMAB AND CONCOMITANT TOPICAL CORTICOSTEROIDS: A 1-YEAR RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL (CHRONOS)
A. Blauvelt et al.
INTERNAL MEDICINE JOURNAL (2017)
Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity A Randomized Clinical Trial
Hugh A. Sampson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease
Monica G. Lawrence et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
The pathophysiology of anaphylaxis
Laurent L. Reber et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective
Brian P. Vickery et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
Stacie M. Jones et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Maurizio Mennini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Positive and Negative Signals in Mast Cell Activation
Silvia Bulfone-Paus et al.
TRENDS IN IMMUNOLOGY (2017)
Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial
Masaya Takahashi et al.
SCIENTIFIC REPORTS (2017)
Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab
Sandra Andorf et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2017)
Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis
S. Dhami et al.
ALLERGY (2017)
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis
S. Dhami et al.
ALLERGY (2017)
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis
U. Nurmatov et al.
ALLERGY (2017)
A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses
F. Zellweger et al.
ALLERGY (2017)
Individually dosed omalizumab: an effective treatment for severe peanut allergy
J. Brandstrom et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
Comparable actions of omalizumab on mast cells and basophils
E. Serrano-Candelas et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Immunoglobulin Glycosylation Effects in Allergy and Immunity
Alexandra Epp et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2016)
IL-33 and Thymic Stromal Lymphopoietin in mast cell functions
Rohit Saluja et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Integrating innate and adaptive immune cells: Mast cells as crossroads between regulatory and effector B and T cells
Yoseph A. Mekori et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Molecular and cellular mechanisms of food allergy and food tolerance
R. Sharon Chinthrajah et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
Robert A. Wood et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch
Stacie M. Jones et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Mast cell desensitization inhibits calcium flux and aberrantly remodels actin
W. X. Gladys Ang et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Cutting Edge: IgE Plays an Active Role in Tumor Immunosurveillance in Mice
Elisa A. Nigro et al.
JOURNAL OF IMMUNOLOGY (2016)
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Luke F. Pennington et al.
NATURE COMMUNICATIONS (2016)
Activated mast cells promote differentiation of B cells into effector cells
Anna-Karin E. Palm et al.
SCIENTIFIC REPORTS (2016)
Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates
Risini D. Weeratna et al.
IMMUNITY INFLAMMATION AND DISEASE (2016)
Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
Andreas Plueckthun
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy
J. A. Wisniewski et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2015)
Mast cell production and response to IL-4 and IL-13
Jamie J. A. McLeod et al.
CYTOKINE (2015)
Structure and dynamics of IgE-receptor interactions: FcεRI and CD23/FcεRII
Brian J. Sutton et al.
IMMUNOLOGICAL REVIEWS (2015)
In vivo allergenic activity of a hypoallergenic mutant of the major fish allergen Cyp c 1 evaluated by means of skin testing
Nikolaos Douladiris et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy
Satya D. Narisety et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens
Alexandra F. Santos et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial
A. Wesley Burks et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Mast cells and dendritic cells form synapses that facilitate antigen transfer for T cell activation
Amanda Carroll-Portillo et al.
JOURNAL OF CELL BIOLOGY (2015)
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H-1 Antihistamines: A Randomized, Placebo-Controlled Study
Sarbjit S. Saini et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Mast cells, basophils and B cell connection network
Sonia Merluzzi et al.
MOLECULAR IMMUNOLOGY (2015)
CD300f associates with IL-4 receptor α and amplifies IL-4-induced immune cell responses
Itay Moshkovits et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial
Elodie Michaud et al.
TRIALS (2015)
Mechanism of the Antigen-Independent Cytokinergic SPE-7 IgE Activation of Human Mast Cells in Vitro
Heather J. Bax et al.
SCIENTIFIC REPORTS (2015)
Mast cells as regulators of T cell responses
Silvia Bulfone-Paus et al.
FRONTIERS IN IMMUNOLOGY (2015)
Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy
Thomas B. Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)
The epidemiology of food allergy in Europe: a systematic review and meta-analysis
B. I. Nwaru et al.
ALLERGY (2014)
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
A. Muraro et al.
ALLERGY (2014)
Two-Allergen Model Reveals Complex Relationship between IgE Crosslinking and Degranulation
Michael W. Handlogten et al.
CHEMISTRY & BIOLOGY (2014)
The role of basophils and proallergic cytokines, TSLP and IL-33, in cutaneously sensitized food allergy
Taichiro Muto et al.
INTERNATIONAL IMMUNOLOGY (2014)
Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells
Alexander Eggel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
New childhood and adult reference intervals for total IgE
Thomas B. Martins et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens
Muebeccel Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
Aidan Long et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Molecular targets on mast cells and basophils for novel therapies
Ilkka T. Harvima et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Inhibitory Fcγ Receptor Is Required for the Maintenance of Tolerance through Distinct Mechanisms
Fubin Li et al.
JOURNAL OF IMMUNOLOGY (2014)
TSLP Induces Mast Cell Development and Aggravates Allergic Reactions through the Activation of MDM2 and STAT6
Na-Ra Han et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial
Katherine Anagnostou et al.
LANCET (2014)
Helminth allergens, parasite-specific IgE, and its protective role in human immunity
Colin Matthew Fitzsimmons et al.
FRONTIERS IN IMMUNOLOGY (2014)
Mast cell mediators: their differential release and the secretory pathways involved
Tae Chul Moon et al.
FRONTIERS IN IMMUNOLOGY (2014)
Siglec-mediated regulation of immune cell function in disease
Matthew S. Macauley et al.
NATURE REVIEWS IMMUNOLOGY (2014)
A phase 1 study of heat/phenol-killed, E.coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy
R. A. Wood et al.
ALLERGY (2013)
Activation/Inhibition of mast cells by supra-optimal antigen concentrations
Michael Huber
CELL COMMUNICATION AND SIGNALING (2013)
Perivascular Mast Cells Dynamically Probe Cutaneous Blood Vessels to Capture Immunoglobulin E
Laurence E. Cheng et al.
IMMUNITY (2013)
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients
Lynda C. Schneider et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial
David M. Fleischer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells
Tatsuya Oka et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice
Yu Liu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
Edwin H. Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice
Laurent L. Reber et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
IL-33 Induces a Hyporesponsive Phenotype in Human and Mouse Mast Cells
Mi-Yeon Jung et al.
JOURNAL OF IMMUNOLOGY (2013)
Important Role for FcγRIIB on B Lymphocytes for Mucosal Antigen-Induced Tolerance and Foxp3+ Regulatory T Cells
Jia-Bin Sun et al.
JOURNAL OF IMMUNOLOGY (2013)
Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy
O. T. Burton et al.
MUCOSAL IMMUNOLOGY (2013)
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Marcus Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells
Marcia A Chan et al.
Clinical and Translational Allergy (2013)
The two faces of mast cells in food allergy and allergic asthma: The possible concept of Yin Yang
Aletta D. Kraneveld et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Modulation of FcεRI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA
Riccardo Sibilano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy
Jessica H. Savage et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody
Seung Y. Chu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy
Michael Kulis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor
Beomkyu Kim et al.
NATURE (2012)
Mast cell: an emerging partner in immune interaction
Giorgia Gri et al.
FRONTIERS IN IMMUNOLOGY (2012)
Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro
M. Elishmereni et al.
ALLERGY (2011)
Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein
A. Eggel et al.
ALLERGY (2011)
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial
Nicola A. Hanania et al.
ANNALS OF INTERNAL MEDICINE (2011)
Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome
K. Anagnostou et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2011)
Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function
Anne Dudeck et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization
Maria del Carmen Sancho-Serra et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Mast Cells Condition Dendritic Cells to Mediate Allograft Tolerance
Victor C. de Vries et al.
IMMUNITY (2011)
A phase II, randomized, double-blind, parallel-group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
Hugh A. Sampson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling
Clinton B. Mathias et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Sublingual immunotherapy for peanut allergy: Clinical and immunologic evidence of desensitization
Edwin H. Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
Pooja Varshney et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Reduced Fc epsilon RI-Mediated Release of Asthma-Promoting Cytokines and Chemokines from Human Basophils during Omalizumab Therapy
Janet M. Oliver et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2010)
Regulation of Syk kinase and FcR beta expression in human basophils during treatment with omalizumab
Asifa K. Zaidi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Oral peanut immunotherapy in children with peanut anaphylaxis
Katharina Blumchen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Decreases in human dendritic cell-dependent TH2-like responses after acute in vivo IgE neutralization
John T. Schroeder et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mast Cells, Histamine, and IL-6 Regulate the Selective Influx of Dendritic Cell Subsets into an. Inflamed Lymph Node
Wojciech Dawicki et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation
Chia-Lin Hsu et al.
PLOS ONE (2010)
Relationships between Levels of Serum IgE, Cell-Bound IgE, and IgE-Receptors on Peripheral Blood Cells in a Pediatric Population
Eleonora Dehlink et al.
PLOS ONE (2010)
Cell-cell cooperation at the T helper cell/mast cell immunological synapse
Nicolas Gaudenzio et al.
BLOOD (2009)
FcεRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells
Y. Okayama et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Bob Lanier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Inhibition of FcεRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement
Hidenori Yokoi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Allergen skin tests and free IgE levels during reduction and cessation of ornalizumab therapy
Jonathan Corren et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a
Ido Bachelet et al.
JOURNAL OF IMMUNOLOGY (2008)
Regulation of the High Affinity IgE Receptor (FcεRI) in Human Neutrophils: Role of Seasonal Allergen Exposure and Th-2 Cytokines
Martin P. Alphonse et al.
PLOS ONE (2008)
Immunomodulatory mast cells: negative, as well as positive, regulators of immunity
Stephen J. Galli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
IgE in allergy and asthma today
Hannah J. Gould et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Endocytosis, recycling, and degradation of unoccupied FcεRI in human basophils
Donald W. MacGlashan
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B
Michele A. Grimbaldeston et al.
NATURE IMMUNOLOGY (2007)
Omalizumab reverses the phenotypic and functional effects of IgE-Enhanced FcεRI on human skin mast cells
Gregorio Gomez et al.
JOURNAL OF IMMUNOLOGY (2007)
New developments in FcεRI regulation, function and inhibition
Stefan Kraft et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Thymic stfomal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells
Zoulfia Allakhverdi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection
A. A. Cruz et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2007)
Egg oral immunotherapy in nonanaphylactic children with egg allergy
Ariana D. Buchanan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Proximal signaling events in Fc epsilon RI-mediated mast cell activation
Taku Kambayashi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding
Sven Klunker et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells
Toshio Kitawaki et al.
INTERNATIONAL IMMUNOLOGY (2006)
Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells
Alessandra Mazzoni et al.
JOURNAL OF IMMUNOLOGY (2006)
Mast cells are essential intermediaries in regulatory T-cell tolerance
Li-Fan Lu et al.
NATURE (2006)
FcγRIIa, not FcγRIIb, is constitutively and functionally expressed on skin-derived human mast cells
Wei Zhao et al.
JOURNAL OF IMMUNOLOGY (2006)
Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells
H Yokoi et al.
ALLERGY (2006)
Mast cell-associated TNF promotes dendritic cell migration
Hajime Suto et al.
JOURNAL OF IMMUNOLOGY (2006)
IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking
RT Strait et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis
TB Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a
Ido Bachelet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
The CD200 receptor is a novel and potent regulator of murine and human mast cell function
HM Cherwinski et al.
JOURNAL OF IMMUNOLOGY (2005)
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma
ST Holgate et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils
H Lin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Omalizumab-induced reductions in mast cell FcεRI expression and function
LA Beck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Characterization of FcεRI-bearing CD123+ blood dendritic cell antigen-2+ plasmacytoid dendritic cells in atopic dermatitis
N Novak et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR
AM Vignola et al.
ALLERGY (2004)
Loss of receptors and IgE in vivo during treatment with anti-IgE antibody
D MacGlashan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Effect of Anti-IgE therapy in patients with peanut allergy
DYM Leung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Oral desensitizing treatment in food allergy: clinical and immunological results
G Patriarca et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Omalizumab treatment downregulates dendritic cell Fc epsilon F-RI expression
C Prussin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
The crystal structure of IgE Fc reveals an asymmetrically bent conformation
T Wan et al.
NATURE IMMUNOLOGY (2002)
A novel human immunoglobulin Fcγ-Fcε bifunctional fusion protein inhibits FcεRI-mediated degranulation
DC Zhu et al.
NATURE MEDICINE (2002)
Detection of novel CD antigens on the surface of human mast cells and basophils
M Ghannadan et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells
G Caron et al.
JOURNAL OF IMMUNOLOGY (2001)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Minimal requirements for IgE-mediated regulation of surface FcεRI
TA Borkowski et al.
JOURNAL OF IMMUNOLOGY (2001)
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M Solèr et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Mast cells as initiators of immunity and host defense
BM Henz et al.
EXPERIMENTAL DERMATOLOGY (2001)
IL-4 and-5 prime human mast cells for different profiles of IgE-dependent cytokine production
H Ochi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The pharmacological basis of anti-IgE therapy
TW Chang
NATURE BIOTECHNOLOGY (2000)
Interleukin-4-induced transcriptional activation by Stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of Stat6
M Pesu et al.
BLOOD (2000)
Share Paper
